Stay updated on Oral Ixazomib Maintenance in NDMM Clinical Trial
Sign up to get notified when there's something new on the Oral Ixazomib Maintenance in NDMM Clinical Trial page.

Latest updates to the Oral Ixazomib Maintenance in NDMM Clinical Trial page
- Check6 days agoChange DetectedRevision history now shows an addition of Revision: v3.4.3 and a deletion of Revision: v3.4.2.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedThe page history shows a new Revision: v3.4.2 entry added and older admin notices (v3.4.1 and funding/operating status messages) removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

- Check41 days agoChange DetectedA site-wide notice about government funding delays has been added and the page revision is now v3.4.1, replacing the previous v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

- Check48 days agoChange DetectedUI updates to the study record history include a Show glossary option, color-coded additions (green) and deletions (red), and a new Revision: v3.4.0 label. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

- Check62 days agoChange DetectedThe page history shows a new revision entry for v3.3.4 added and the previous v3.3.3 entry removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check84 days agoChange DetectedRevision history shows a new entry v3.3.3 added, and HHS Vulnerability Disclosure plus revision v3.3.2 removed from the footer, indicating minor site policy updates. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to Oral Ixazomib Maintenance in NDMM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Oral Ixazomib Maintenance in NDMM Clinical Trial page.